NCT01775904View on ClinicalTrials.gov

A Study of Two Dosage Forms of LY2886721 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

LY2886721 in a Capsule

Administered orally.

DRUG

LY2886721 in an orally disintegrating tablet (ODT)

Administered orally.

Trial Locations (1)

53704

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01775904 - A Study of Two Dosage Forms of LY2886721 in Healthy Participants | Biotech Hunter | Biotech Hunter